RESULTS
The final cohort was constituted by 382 adult patients; of those
patients, 260(68.1%) were discharged on VKA and 122(31.9%) were
discharged on NOACs.
Pre-operative use of oral anticoagulant was recorded in 193 patients
(73.2%) for chronic AF, previous mechanical valve or deep venous
thrombosis (Table 1).
In the overall cohort no ischemic or thromboembolic event were recorded
both in the immediate post-operative course, both at median follow-up.
The median length of stay was 9.5 days (IQR: 7-14). There was no
intra-hospital mortality and all the patients were alive at the
follow-up (median 23.9 months, IQR:18-30).